asthma and lung uk
asthma and lung uk Company Information
Group Structure
View All
Industry
Other human health activities
Registered Address
the white chapel building, 10 whitechapel high street, london, E1 8QS
Website
http://blf.org.ukasthma and lung uk Estimated Valuation
Pomanda estimates the enterprise value of ASTHMA AND LUNG UK at £10m based on a Turnover of £14.8m and 0.68x industry multiple (adjusted for size and gross margin).
asthma and lung uk Estimated Valuation
Pomanda estimates the enterprise value of ASTHMA AND LUNG UK at £0 based on an EBITDA of £-1.2m and a 5.22x industry multiple (adjusted for size and gross margin).
asthma and lung uk Estimated Valuation
Pomanda estimates the enterprise value of ASTHMA AND LUNG UK at £28.7m based on Net Assets of £12.2m and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Asthma And Lung Uk Overview
Asthma And Lung Uk is a live company located in london, E1 8QS with a Companies House number of 01863614. It operates in the other human health activities sector, SIC Code 86900. Founded in November 1984, it's largest shareholder is unknown. Asthma And Lung Uk is a mature, mid sized company, Pomanda has estimated its turnover at £14.8m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Asthma And Lung Uk Health Check
Pomanda's financial health check has awarded Asthma And Lung Uk a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 6 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
6 Weak
Size
annual sales of £14.8m, make it larger than the average company (£684.9k)
£14.8m - Asthma And Lung Uk
£684.9k - Industry AVG
Growth
3 year (CAGR) sales growth of -1%, show it is growing at a slower rate (8.1%)
-1% - Asthma And Lung Uk
8.1% - Industry AVG
Production
with a gross margin of 39.1%, this company has a comparable cost of product (39.1%)
39.1% - Asthma And Lung Uk
39.1% - Industry AVG
Profitability
an operating margin of -10.3% make it less profitable than the average company (5.4%)
-10.3% - Asthma And Lung Uk
5.4% - Industry AVG
Employees
with 195 employees, this is above the industry average (17)
195 - Asthma And Lung Uk
17 - Industry AVG
Pay Structure
on an average salary of £46.9k, the company has a higher pay structure (£27.5k)
£46.9k - Asthma And Lung Uk
£27.5k - Industry AVG
Efficiency
resulting in sales per employee of £75.7k, this is more efficient (£49.2k)
£75.7k - Asthma And Lung Uk
£49.2k - Industry AVG
Debtor Days
it gets paid by customers after 6 days, this is earlier than average (20 days)
6 days - Asthma And Lung Uk
20 days - Industry AVG
Creditor Days
its suppliers are paid after 12 days, this is quicker than average (16 days)
12 days - Asthma And Lung Uk
16 days - Industry AVG
Stock Days
it holds stock equivalent to 1 days, this is less than average (15 days)
1 days - Asthma And Lung Uk
15 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 17 weeks, this is less cash available to meet short term requirements (108 weeks)
17 weeks - Asthma And Lung Uk
108 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 51.7%, this is a higher level of debt than the average (25.2%)
51.7% - Asthma And Lung Uk
25.2% - Industry AVG
ASTHMA AND LUNG UK financials
Asthma And Lung Uk's latest turnover from June 2024 is £14.8 million and the company has net assets of £12.2 million. According to their latest financial statements, Asthma And Lung Uk has 195 employees and maintains cash reserves of £3.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 14,769,000 | 14,707,000 | 13,939,000 | 15,105,000 | 20,089,000 | 8,507,000 | 9,589,000 | 7,507,000 | 7,000,000 | 6,647,000 | 6,103,961 | 6,130,571 | 6,375,679 | 7,161,841 | 8,288,988 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | -1,338,000 | 389,000 | -2,235,000 | 1,847,000 | 9,297,000 | -296,000 | 207,000 | -605,000 | -898,000 | 76,000 | 435,702 | -1,025,316 | -935,706 | -27,068 | 2,394,250 |
| Tax | |||||||||||||||
| Profit After Tax | -1,338,000 | 389,000 | -2,235,000 | 1,847,000 | 9,297,000 | -296,000 | 207,000 | -605,000 | -898,000 | 76,000 | 435,702 | -1,025,316 | -935,706 | -27,068 | 2,394,250 |
| Dividends Paid | |||||||||||||||
| Retained Profit | -1,338,000 | 389,000 | -2,235,000 | 1,847,000 | 9,297,000 | -296,000 | 207,000 | -605,000 | -898,000 | 76,000 | 435,702 | -1,025,316 | -935,706 | -27,068 | 2,394,250 |
| Employee Costs | 9,137,000 | 8,023,000 | 7,374,000 | 6,950,000 | 5,526,000 | 3,260,000 | 3,569,000 | 3,265,000 | 3,160,000 | 2,921,000 | 2,607,262 | 3,401,190 | 2,948,521 | 2,656,213 | 2,643,233 |
| Number Of Employees | 195 | 179 | 167 | 158 | 136 | 93 | 94 | 86 | 82 | 81 | 64 | 87 | 85 | 76 | 72 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 939,000 | 173,000 | 393,000 | 887,000 | 861,000 | 896,000 | 896,000 | 932,000 | 968,000 | 1,048,000 | 1,063,382 | 1,113,739 | 1,158,885 | 1,145,359 | 1,188,745 |
| Intangible Assets | 704,000 | 900,000 | |||||||||||||
| Investments & Other | 18,282,000 | 19,543,000 | 18,950,000 | 17,589,000 | 15,497,000 | 5,599,000 | 5,654,000 | 5,484,000 | 5,146,000 | 6,320,000 | 6,231,841 | 4,953,028 | 5,556,430 | 6,844,600 | 3,610,765 |
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 19,925,000 | 20,616,000 | 19,343,000 | 18,476,000 | 16,358,000 | 6,495,000 | 6,550,000 | 6,416,000 | 6,114,000 | 7,368,000 | 7,295,223 | 6,066,767 | 6,715,315 | 7,989,959 | 4,799,510 |
| Stock & work in progress | 28,000 | 27,000 | 22,000 | ||||||||||||
| Trade Debtors | 254,000 | 56,000 | 200,000 | 88,000 | 62,000 | 33,000 | 29,000 | 77,000 | 411,000 | 302,000 | 718,783 | 1,544,650 | 699,601 | 496,279 | 537,995 |
| Group Debtors | |||||||||||||||
| Misc Debtors | 1,624,000 | 1,649,000 | 1,470,000 | 1,982,000 | 1,549,000 | 968,000 | 1,136,000 | 254,000 | 142,000 | 247,000 | |||||
| Cash | 3,475,000 | 3,399,000 | 5,128,000 | 7,404,000 | 5,022,000 | 3,804,000 | 3,493,000 | 2,781,000 | 2,079,000 | 1,622,000 | 1,066,098 | 941,441 | 816,457 | 2,046,915 | 4,062,624 |
| misc current assets | 679,059 | 1,562,860 | 1,923,686 | ||||||||||||
| total current assets | 5,381,000 | 5,131,000 | 6,820,000 | 9,474,000 | 6,633,000 | 4,805,000 | 4,658,000 | 3,112,000 | 2,632,000 | 2,171,000 | 2,463,940 | 4,048,951 | 3,439,744 | 2,543,194 | 4,600,619 |
| total assets | 25,306,000 | 25,747,000 | 26,163,000 | 27,950,000 | 22,991,000 | 11,300,000 | 11,208,000 | 9,528,000 | 8,746,000 | 9,539,000 | 9,759,163 | 10,115,718 | 10,155,059 | 10,533,153 | 9,400,129 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 299,000 | 60,000 | 210,000 | 995,000 | 513,000 | 531,000 | 360,000 | 373,000 | 343,000 | 702,000 | |||||
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 9,808,000 | 9,468,000 | 8,071,000 | 8,156,000 | 6,264,000 | 3,856,000 | 4,023,000 | 2,812,000 | 2,230,000 | 1,726,000 | 1,433,081 | 2,856,500 | 2,058,386 | 1,858,495 | 774,839 |
| total current liabilities | 10,107,000 | 9,528,000 | 8,281,000 | 9,151,000 | 6,777,000 | 4,387,000 | 4,383,000 | 3,185,000 | 2,573,000 | 2,428,000 | 1,433,081 | 2,856,500 | 2,058,386 | 1,858,495 | 774,839 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | 2,986,000 | 2,668,000 | 4,720,000 | 3,402,000 | 2,664,000 | 1,593,000 | 1,209,000 | 1,073,000 | 611,000 | 554,000 | 1,803,005 | 1,426,196 | 1,528,191 | 1,107,396 | |
| provisions | |||||||||||||||
| total long term liabilities | 2,986,000 | 2,668,000 | 4,720,000 | 3,402,000 | 2,664,000 | 1,593,000 | 1,209,000 | 1,073,000 | 611,000 | 554,000 | 1,803,005 | 1,426,196 | 1,528,191 | 1,107,396 | |
| total liabilities | 13,093,000 | 12,196,000 | 13,001,000 | 12,553,000 | 9,441,000 | 5,980,000 | 5,592,000 | 4,258,000 | 3,184,000 | 2,982,000 | 3,236,086 | 4,282,696 | 3,586,577 | 2,965,891 | 774,839 |
| net assets | 12,213,000 | 13,551,000 | 13,162,000 | 15,397,000 | 13,550,000 | 5,320,000 | 5,616,000 | 5,270,000 | 5,562,000 | 6,557,000 | 6,523,077 | 5,833,022 | 6,568,482 | 7,567,262 | 8,625,290 |
| total shareholders funds | 12,213,000 | 13,551,000 | 13,162,000 | 15,397,000 | 13,550,000 | 5,320,000 | 5,616,000 | 5,270,000 | 5,562,000 | 6,557,000 | 6,523,077 | 5,833,022 | 6,568,482 | 7,567,262 | 8,625,290 |
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 121,000 | 80,000 | 73,000 | 60,000 | 35,000 | 32,000 | 36,000 | 44,000 | 61,000 | 57,000 | 56,075 | 69,767 | 76,214 | 73,341 | 112,176 |
| Amortisation | 196,000 | 48,000 | |||||||||||||
| Tax | |||||||||||||||
| Stock | 1,000 | 5,000 | 22,000 | ||||||||||||
| Debtors | 173,000 | 35,000 | -400,000 | 459,000 | 610,000 | -164,000 | 834,000 | -222,000 | 4,000 | -169,783 | -825,867 | 845,049 | 203,322 | -41,716 | 537,995 |
| Creditors | 239,000 | -150,000 | -785,000 | 482,000 | -18,000 | 171,000 | -13,000 | 30,000 | -359,000 | 702,000 | |||||
| Accruals and Deferred Income | 340,000 | 1,397,000 | -85,000 | 1,892,000 | 2,408,000 | -167,000 | 1,211,000 | 582,000 | 504,000 | 292,919 | -1,423,419 | 798,114 | 199,891 | 1,083,656 | 774,839 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | -31,000 | -33,000 | -1,030,178 | -235,842 | 1,135,356 | -3,007,716 | -1,361,048 | ||||||||
| Change in Investments | -1,261,000 | 593,000 | 1,361,000 | 2,092,000 | 9,898,000 | -55,000 | 170,000 | 338,000 | -1,174,000 | 88,159 | 1,278,813 | -603,402 | -1,288,170 | 3,233,835 | 3,610,765 |
| cash flow from investments | 1,261,000 | -593,000 | -1,361,000 | -2,092,000 | -9,898,000 | 55,000 | -201,000 | -371,000 | 1,174,000 | -88,159 | -2,308,991 | 367,560 | 2,423,526 | -6,241,551 | -4,971,813 |
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | 318,000 | -2,052,000 | 1,318,000 | 738,000 | 1,071,000 | 384,000 | 136,000 | 462,000 | 57,000 | -1,249,005 | 376,809 | -101,995 | 420,795 | 1,107,396 | |
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | 318,000 | -2,052,000 | 1,318,000 | 738,000 | 4,000 | 384,000 | 275,000 | 775,000 | -40,000 | -1,291,082 | 631,162 | 187,861 | 357,721 | 76,436 | 6,231,040 |
| cash and cash equivalents | |||||||||||||||
| cash | 76,000 | -1,729,000 | -2,276,000 | 2,382,000 | 1,218,000 | 311,000 | 712,000 | 702,000 | 457,000 | 555,902 | 124,657 | 124,984 | -1,230,458 | -2,015,709 | 4,062,624 |
| overdraft | |||||||||||||||
| change in cash | 76,000 | -1,729,000 | -2,276,000 | 2,382,000 | 1,218,000 | 311,000 | 712,000 | 702,000 | 457,000 | 555,902 | 124,657 | 124,984 | -1,230,458 | -2,015,709 | 4,062,624 |
asthma and lung uk Credit Report and Business Information
Asthma And Lung Uk Competitor Analysis
Perform a competitor analysis for asthma and lung uk by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in E 1 area or any other competitors across 12 key performance metrics.
asthma and lung uk Ownership
ASTHMA AND LUNG UK group structure
Asthma And Lung Uk has 3 subsidiary companies.
Ultimate parent company
ASTHMA AND LUNG UK
01863614
3 subsidiaries
asthma and lung uk directors
Asthma And Lung Uk currently has 13 directors. The longest serving directors include Mrs Katherine Morgan (Jan 2020) and Professor Ian Hall (Jan 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Katherine Morgan | 45 years | Jan 2020 | - | Director | |
| Professor Ian Hall | Uk | 67 years | Jan 2020 | - | Director |
| Professor Ian Sabroe | England | 59 years | Jan 2020 | - | Director |
| Niren Patel | 40 years | Jan 2020 | - | Director | |
| Mr James Bowes | England | 44 years | Jan 2020 | - | Director |
| Mr Niren Patel | 40 years | Jan 2020 | - | Director | |
| Mrs Caroline Cartellieri Karlsen | 54 years | Feb 2021 | - | Director | |
| Mr Michael O'Connor | 68 years | Feb 2021 | - | Director | |
| Ms Tamara Ingram | United Kingdom | 64 years | Nov 2022 | - | Director |
| Mr Victor Cholij | England | 63 years | Jun 2023 | - | Director |
P&L
June 2024turnover
14.8m
0%
operating profit
-1.5m
0%
gross margin
39.2%
+0.7%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
12.2m
-0.1%
total assets
25.3m
-0.02%
cash
3.5m
+0.02%
net assets
Total assets minus all liabilities
asthma and lung uk company details
company number
01863614
Type
Private Ltd By Guarantee w/o Share Cap
industry
86900 - Other human health activities
incorporation date
November 1984
age
41
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
June 2024
previous names
asthma uk and british lung foundation partnership (February 2022)
british lung foundation (January 2020)
accountant
-
auditor
CROWE U.K. LLP
address
the white chapel building, 10 whitechapel high street, london, E1 8QS
Bank
HSBC BANK PLC
Legal Advisor
BATES WELLS LLP
asthma and lung uk Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to asthma and lung uk.
asthma and lung uk Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ASTHMA AND LUNG UK. This can take several minutes, an email will notify you when this has completed.
asthma and lung uk Companies House Filings - See Documents
| date | description | view/download |
|---|
